ストックスクリーナーアプリを入手
25.95
0.54%
-0.14
アフターアワーズ：
25.85
-0.10
-0.39%
前日終値:
$26.09
開ける：
$26.53
24時間の取引高:
2.84M
Relative Volume:
1.05
時価総額：
$2.22B
収益：
$17.49M
当期純損益:
$-78.50M
株価収益率:
-21.62
EPS:
-1.2
ネットキャッシュフロー:
$-52.85M
1週間 パフォーマンス:
+26.89%
1か月 パフォーマンス:
+78.84%
6か月 パフォーマンス:
+60.19%
1年 パフォーマンス:
+87.64%
1日の値動き範囲:
$25.75
$26.53
1週間の範囲:
$19.90
$26.65
52週間の値動き範囲:
$8.26
$26.65
Liquidia Corp Stock (LQDA) Company Profile
名前
Liquidia Corp
セクター
電話
919.328.4400
住所
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
LQDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
25.95 | 2.25B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-15 | 再開されました | Jefferies | Buy |
| 2025-05-19 | ダウングレード | Oppenheimer | Perform → Underperform |
| 2024-12-20 | 開始されました | Wells Fargo | Overweight |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | 開始されました | Raymond James | Outperform |
| 2024-06-25 | 開始されました | Oppenheimer | Perform |
| 2024-01-05 | 繰り返されました | Needham | Buy |
| 2022-09-19 | 再開されました | Wedbush | Underperform |
| 2022-09-01 | ダウングレード | Wedbush | Neutral → Underperform |
| 2022-07-22 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-05-31 | 開始されました | BTIG Research | Buy |
| 2022-05-26 | 開始されました | BofA Securities | Buy |
| 2020-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-11-08 | 再開されました | Jefferies | Buy |
| 2018-09-05 | 開始されました | Wedbush | Outperform |
| 2018-08-20 | 開始されました | Jefferies | Buy |
| 2018-08-20 | 開始されました | Needham | Buy |
すべてを表示
Liquidia Corp (LQDA) 最新ニュース
Jefferies initiates Liquidia stock with Buy rating, $43 price target - Investing.com
Jefferies initiates Liquidia stock with Buy rating, $43 price target By Investing.com - Investing.com UK
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Liquidia Technologies stock hits 52-week high at 25.19 USD - Investing.com
Liquidia's Q2 Results Boost Analyst Forecasts, Shares Rise - AInvest
Liquidia's Yutrepia Prescriptions Soar, Shares Rise 13.68% - AInvest
Liquidia (LQDA) Climbs 13.68% as Yutrepia Prescriptions Surge - Insider Monkey
Liquidia (LQDA) Rating Maintained as Strong Buy by Raymond James - GuruFocus
Wells Fargo Raises Liquidia (LQDA) Price Target to $31 | LQDA St - GuruFocus
Liquidia Corporation (NASDAQ:LQDA) Q2 2025 Earnings Call Transcript - Insider Monkey
Liquidia: Raymond James maintains Strong Buy, raises PT to $41 from $33. - AInvest
Wells Fargo Raises Liquidia PT to $31 from $25, Maintains Overweight Rating - AInvest
Liquidia stock price target raised to $31 by Wells Fargo on strong launch - Investing.com Canada
Liquidia stock price target raised to $49 from $40 at BTIG - Investing.com
Liquidia: Needham Raises PT to $36 from $32, Maintains Buy Rating - AInvest
Liquidia 2025 Q2 Earnings Wider Losses Despite Revenue Surge - AInvest
Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YUTREPIA Launch and Financial Position - Yahoo Finance
Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YU - GuruFocus
Decoding Liquidia Corp (LQDA): A Strategic SWOT Insight - GuruFocus
10 Stocks on Euphoria. Are You Holding Any? - Insider Monkey
United Therapeutics Shares Rise 0.32% Amid Patent Dispute with Liquidia Trading Volume Ranked 420th in Market Activity - AInvest
Liquidia Corporation shares rise 15.19% intraday after reporting positive interim data from ASCENT trial. - AInvest
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Liquidia Stock Surges as Q2 Earnings Beat Expectations - AInvest
Liquidia (LQDA): A High-Growth Biotech Play with Explosive Revenue Momentum and a Path to Profitability - AInvest
Liquidia's Q2 2025 Earnings Call: Unpacking Key Contradictions on YUTREPIA's Market Access and Data Presentation - AInvest
Liquidia Corporation Q2 2025 Earnings Call Transcript Analysis: Key Takeaways and Insights - AInvest
Liquidia Sees Boost in YUTREPIA Adoption, Aims for Expanded Market Access in H2 2025. - AInvest
When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - 富途牛牛
Earnings call transcript: Liquidia Q2 2025 sees revenue surge, stock jumps - Investing.com
Liquidia Q2 2025 slides: Yutrepia launch drives 141% revenue growth amid widening losses - Investing.com
Liquidia Corporation shares surge 13.44% in premarket after strong Q2 earnings and positive drug trial results. - AInvest
Liquidia Stock Soars 10.61% on Q2 Earnings - AInvest
Liquidia Technologies earnings missed by $0.07, revenue topped estimates - Investing.com
Liquidia Corp SEC 10-Q Report - TradingView
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update - TradingView
Liquidia Q2 2025 Earnings Preview: Key Estimates and Trends - AInvest
Earnings To Watch: Liquidia Corp (LQDA) Reports Q2 2025 Result - Yahoo Finance
Liquidia (LQDA): Navigating Legal Uncertainty and YUTREPIA's Launch to Unlock Hidden Value - AInvest
Liquidia: Uncertainty Has Always Been A Buying Opportunity (LQDA) - Seeking Alpha
Will Liquidia Corporation Sustain Its Chart BreakoutReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Liquidia Corp expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Liquidia Corporation's Profit Outlook: A Comprehensive Analysis of the Biopharmaceutical Company's Future Prospects - AInvest
Liquidia Corporation's (NASDAQ:LQDA) Profit Outlook - Yahoo Finance
Liquidia Technologies Experiences Promising Start with Yutrepia's Strong Launch - AInvest
Liquidia Technologies stock hits 52-week high at 20.33 USD - Investing.com
Liquidia Technologies stock hits 52-week high at 20.33 USD By Investing.com - Investing.com UK
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12 - Quiver Quantitative
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times
How does Liquidia Corporation generate profit in a changing economyConsistently outstanding ROI - Jammu Links News
What analysts say about Liquidia Corporation stockTremendous growth potential - Jammu Links News
Liquidia Corp (LQDA) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):